US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

NEWAMSTERDAM PHARMA CO NV

25.34

-0.5600-2.16%

Pre-market: 25.750.4100+1.62%05:09 EDT

Volume:1.55M

Turnover:38.86M

Market Cap:3.03B

PE:-11.82

High:25.65

Open:25.65

Low:24.80

Close:25.90

52wk High:42.21

52wk Low:23.05

Shares:119.54M

Float Shares:92.51M

Volume Ratio:1.39

T/O Rate:1.67%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.1442

EPS(LYR):-1.7211

ROE:-36.81%

ROA:-20.11%

PB:4.80

PE(LYR):-14.72

Loading ...

Overview Company News Filings

Stock Track | NewAmsterdam Pharma Soars 5.31% Intraday on Guggenheim's Buy Rating

Wall Street Analysts Are Bullish on Top Healthcare Picks

Guggenheim Sticks to Their Buy Rating for NewAmsterdam Pharma Company (NAMS)

NewAmsterdam Pharma Company NV reports results for the quarter ended March 31 - Earnings Summary

NewAmsterdam Pharma Q1 net loss widens to USD 48.4 million

Press Release: NewAmsterdam Pharma Provides Corporate Update and Reports First Quarter Financial Results

NewAmsterdam Pharma grants 50,400 inducement share options at $28.43 per share

NewAmsterdam Pharma Chief Accounting Officer Louise Kooij to depart Aug. 31

China National Investment & Guaranty Refutes Collaboration Claims with NAMS on Investment Products

NewAmsterdam Pharma announces annual shareholder meeting

A Look At NewAmsterdam Pharma (NAMS) Valuation After Positive Obicetrapib Trial Sentiment And ACC.26 Data Presentations

Simply Wall St.

NewAmsterdam Pharma grants 15,000 inducement options under Nasdaq Rule 5635(c)(4)

Will ACC.26 Obicetrapib Data on Kidney, Safety and Lipids Change NewAmsterdam Pharma's (NAMS) Narrative?

Simply Wall St.

NewAmsterdam Pharma published BROADWAY trial presentation; pooled BROADWAY and BROOKLYN analysis shows slower annualized eGFR decline on obicetrapib vs placebo

NewAmsterdam Pharma publishes pooled Phase III safety presentation on obicetrapib; TEAEs fall to 60.2% from 62.0%

NewAmsterdam Pharma posts BROADWAY trial presentation on obicetrapib kidney outcomes

NewAmsterdam Pharma to present BROADWAY trial results on obicetrapib at ACC.26

Truist Initiates NewAmsterdam Pharma at Buy With $57 Price Target

MT Newswires Live

NewAmsterdam Pharma initiated with a Buy at Truist

NewAmsterdam Pharma Reports Nasdaq-Rule Inducement Grants Under 2024 Inducement Plan

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/NAMS/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NAMS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NAMS\",,,,,undefined,":{"symbol":"NAMS","market":"US","secType":"STK","nameCN":"NEWAMSTERDAM PHARMA CO NV","latestPrice":25.34,"timestamp":1788206400000,"preClose":25.9,"halted":0,"volume":1546249,"hourTrading":{"tag":"盘前","latestPrice":25.75,"preClose":25.34,"latestTime":"05:09 EDT","volume":100,"amount":2574.55,"timestamp":1788253764886,"change":0.41,"changeRate":0.01618,"amplitude":0.005919},"delay":0,"changeRate":-0.021621621621621574,"floatShares":92512947,"shares":119537169,"eps":-2.144229,"marketStatus":"Pre-Mkt","change":-0.56,"latestTime":"09-01 05:21:02 EDT","open":25.65,"high":25.65,"low":24.8,"amount":38864272.80295,"amplitude":0.032819,"askPrice":25.77,"askSize":47,"bidPrice":24.76,"bidSize":47,"shortable":3,"etf":0,"ttmEps":-2.144229,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788269400000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":25.34,"preHourTrading":{"tag":"盘前","latestPrice":25.75,"preClose":25.34,"latestTime":"05:09 EDT","volume":100,"amount":2574.55,"timestamp":1788253764886,"change":0.41,"changeRate":0.01618,"amplitude":0.005919},"postHourTrading":{"tag":"盘后","latestPrice":26.35,"preClose":25.34,"latestTime":"19:30 EDT","volume":73944,"amount":1874398.973032,"timestamp":1788219002870,"change":1.01,"changeRate":0.039858,"amplitude":0.039858},"volumeRatio":1.3899482115048196,"impliedVol":0.95,"impliedVolPercentile":0.8924},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NAMS\",,,,,undefined,":{"symbol":"NAMS","floatShares":92512947,"roa":"-20.11%","roe":"-36.81%","lyrEps":-1.721092,"volumeRatio":1.3899482115048196,"shares":119537169,"dividePrice":0,"high":25.65,"amplitude":0.032819,"preClose":25.9,"low":24.8,"week52Low":23.05,"pbRate":"4.80","psRate":"425.37","week52High":42.205,"institutionHeld":0,"latestPrice":25.34,"eps":-2.144229,"divideRate":0,"volume":1546249,"delay":0,"ttmEps":-2.144229,"open":25.65,"prevYearClose":35.08,"prevWeekClose":25.9,"prevMonthClose":25.34,"prevQuarterClose":33.89,"fiveDayClose":26.85,"twentyDayClose":27.49,"sixtyDayClose":32.67},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NAMS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-05","symbol":"NAMS","fiscalQuarterEnding":"2026/06","expectedEps":-0.48,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785902400000,"reportTimeType":"pre","actualEps":-0.52},{"market":"US","date":"2026-05-07","symbol":"NAMS","fiscalQuarterEnding":"2026/03","expectedEps":-0.46,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"pre","actualEps":-0.4},{"date":"2026-02-18","symbol":"NAMS","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1771405200000,"name":null,"time":"Pre-MKt","dateTimestamp":1771390800000,"actualEps":null},{"market":"US","date":"2025-11-05","symbol":"NAMS","fiscalQuarterEnding":"2025/09","expectedEps":-0.38,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762318800000,"reportTimeType":"pre","actualEps":-0.41},{"market":"US","date":"2025-08-06","symbol":"NAMS","fiscalQuarterEnding":"2025/06","expectedEps":-0.52,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754452800000,"reportTimeType":"pre","actualEps":-0.15}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NAMS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NAMS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4118,"buy":0.5294,"hold":0.0588,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5294,"analysts":17,"updateTime":1784779200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NAMS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NAMS","date":"2026-08-28","current":-11.817768,"percent":0.472742,"low":-27.491906,"twenty":-20.881502,"median":-11.672791,"eighty":-4.993803,"high":37.547018,"avg":-10.517619,"sd":12.056129,"marketCap":3202400757},"quantilePoints":[{"date":"2021-09-03","current":-20.932843,"twenty":-20.9331,"median":-20.51883,"eighty":-20.267469,"marketCap":143010000},{"date":"2021-09-10","current":-20.672351,"twenty":-20.952117,"median":-20.526525,"eighty":-20.273344,"marketCap":140578830},{"date":"2021-09-17","current":-20.788911,"twenty":-20.935877,"median":-20.538007,"eighty":-20.294251,"marketCap":140292810},{"date":"2021-09-24","current":-20.925132,"twenty":-20.932894,"median":-20.56006,"eighty":-20.301276,"marketCap":140864850},{"date":"2021-10-01","current":-21.007107,"twenty":-20.973142,"median":-20.575716,"eighty":-20.306471,"marketCap":140006790},{"date":"2021-10-08","current":-21.151111,"twenty":-21.00809,"median":-20.581853,"eighty":-20.310016,"marketCap":140721840},{"date":"2021-10-15","current":-20.992495,"twenty":-21.033503,"median":-20.614435,"eighty":-20.314138,"marketCap":140006790},{"date":"2021-10-22","current":-20.979254,"twenty":-21.015601,"median":-20.620294,"eighty":-20.319189,"marketCap":140292810},{"date":"2021-10-29","current":-21.103709,"twenty":-21.049534,"median":-20.628022,"eighty":-20.340912,"marketCap":140292810},{"date":"2021-11-05","current":-21.161406,"twenty":-21.059496,"median":-20.645111,"eighty":-20.350832,"marketCap":140578830},{"date":"2021-11-12","current":-21.337744,"twenty":-21.068902,"median":-20.670206,"eighty":-20.353037,"marketCap":140435820},{"date":"2021-11-19","current":-21.577137,"twenty":-21.091056,"median":-20.678231,"eighty":-20.353298,"marketCap":140435820},{"date":"2021-11-26","current":-21.52096,"twenty":-21.108578,"median":-20.693694,"eighty":-20.355018,"marketCap":140006790},{"date":"2021-12-03","current":-21.5525,"twenty":-21.125131,"median":-20.706276,"eighty":-20.35641,"marketCap":139863780},{"date":"2021-12-10","current":-21.569806,"twenty":-21.155229,"median":-20.729118,"eighty":-20.357488,"marketCap":140292810},{"date":"2021-12-17","current":-21.444455,"twenty":-21.18744,"median":-20.755321,"eighty":-20.360981,"marketCap":139005720},{"date":"2021-12-23","current":-21.411047,"twenty":-21.239434,"median":-20.778281,"eighty":-20.367381,"marketCap":139291740},{"date":"2021-12-31","current":-21.326314,"twenty":-21.328981,"median":-20.793694,"eighty":-20.376349,"marketCap":139434750},{"date":"2022-01-07","current":-21.496624,"twenty":-21.347524,"median":-20.831373,"eighty":-20.380063,"marketCap":140149800},{"date":"2022-01-14","current":-21.343042,"twenty":-21.350709,"median":-20.845796,"eighty":-20.384765,"marketCap":140149800},{"date":"2022-01-21","current":-21.439355,"twenty":-21.390606,"median":-20.871892,"eighty":-20.394177,"marketCap":139792275},{"date":"2022-01-28","current":-21.81807,"twenty":-21.411007,"median":-20.878577,"eighty":-20.407434,"marketCap":140006790},{"date":"2022-02-04","current":-21.195343,"twenty":-21.415476,"median":-20.901854,"eighty":-20.412214,"marketCap":139434750},{"date":"2022-02-11","current":-21.331112,"twenty":-21.429778,"median":-20.921405,"eighty":-20.419903,"marketCap":139863780},{"date":"2022-02-18","current":-21.489301,"twenty":-21.43906,"median":-20.931009,"eighty":-20.423447,"marketCap":140006790},{"date":"2022-02-25","current":-21.593859,"twenty":-21.452754,"median":-20.936467,"eighty":-20.427355,"marketCap":139863780},{"date":"2022-03-04","current":-22.31244,"twenty":-21.464918,"median":-20.972644,"eighty":-20.428933,"marketCap":140006790},{"date":"2022-03-11","current":-22.266973,"twenty":-21.496624,"median":-20.979146,"eighty":-20.432589,"marketCap":140149800},{"date":"2022-03-18","current":-22.060307,"twenty":-21.513575,"median":-20.987624,"eighty":-20.434714,"marketCap":140292810},{"date":"2022-03-25","current":-22.254443,"twenty":-21.52344,"median":-20.998804,"eighty":-20.447221,"marketCap":140578830},{"date":"2022-04-01","current":-22.154187,"twenty":-21.542769,"median":-21.012022,"eighty":-20.451813,"marketCap":140578830},{"date":"2022-04-08","current":-22.481854,"twenty":-21.567321,"median":-21.030475,"eighty":-20.452843,"marketCap":140578830},{"date":"2022-04-14","current":-22.67216,"twenty":-21.569768,"median":-21.052463,"eighty":-20.467141,"marketCap":140864850},{"date":"2022-04-22","current":-22.730966,"twenty":-21.579562,"median":-21.057477,"eighty":-20.474288,"marketCap":140864850},{"date":"2022-04-29","current":-23.274023,"twenty":-21.614609,"median":-21.067729,"eighty":-20.476303,"marketCap":141007860},{"date":"2022-05-06","current":-23.127906,"twenty":-21.66066,"median":-21.076365,"eighty":-20.478189,"marketCap":140864850},{"date":"2022-05-13","current":-23.491752,"twenty":-21.687663,"median":-21.09477,"eighty":-20.47859,"marketCap":140578830},{"date":"2022-05-20","current":-23.178757,"twenty":-21.820243,"median":-21.108122,"eighty":-20.48606,"marketCap":140578830},{"date":"2022-05-27","current":-22.893849,"twenty":-21.850993,"median":-21.120918,"eighty":-20.491024,"marketCap":141007860},{"date":"2022-06-03","current":-22.874754,"twenty":-21.920045,"median":-21.125878,"eighty":-20.495924,"marketCap":140950656},{"date":"2022-06-10","current":-23.37928,"twenty":-22.019208,"median":-21.131171,"eighty":-20.503856,"marketCap":141436890},{"date":"2022-06-17","current":-23.535903,"twenty":-22.073973,"median":-21.161634,"eighty":-20.508764,"marketCap":141579900},{"date":"2022-06-24","current":-23.228366,"twenty":-22.168168,"median":-21.177519,"eighty":-20.510788,"marketCap":140864850},{"date":"2022-07-01","current":-23.628446,"twenty":-22.205389,"median":-21.200156,"eighty":-20.514249,"marketCap":141293880},{"date":"2022-07-08","current":-24.122583,"twenty":-22.267227,"median":-21.212539,"eighty":-20.517301,"marketCap":141150870},{"date":"2022-07-15","current":-24.331277,"twenty":-22.320478,"median":-21.237179,"eighty":-20.518474,"marketCap":141150870},{"date":"2022-07-22","current":-24.090008,"twenty":-22.423227,"median":-21.257719,"eighty":-20.52015,"marketCap":141579900},{"date":"2022-07-29","current":-24.168576,"twenty":-22.534118,"median":-21.31615,"eighty":-20.524441,"marketCap":141722910},{"date":"2022-08-05","current":-4.879205,"twenty":-22.582014,"median":-21.326314,"eighty":-20.52015,"marketCap":141722910},{"date":"2022-08-12","current":-4.837995,"twenty":-22.549115,"median":-21.276097,"eighty":-20.510261,"marketCap":141865920},{"date":"2022-08-19","current":-4.945659,"twenty":-22.534118,"median":-21.248455,"eighty":-20.488701,"marketCap":142008930},{"date":"2022-08-26","current":-4.973006,"twenty":-22.502765,"median":-21.218542,"eighty":-20.475462,"marketCap":142151940},{"date":"2022-09-02","current":-4.964584,"twenty":-22.470606,"median":-21.200156,"eighty":-20.448139,"marketCap":142437960},{"date":"2022-09-09","current":-4.95567,"twenty":-22.425612,"median":-21.178962,"eighty":-20.428933,"marketCap":142296380},{"date":"2022-09-16","current":-4.974555,"twenty":-22.424465,"median":-21.161634,"eighty":-20.410452,"marketCap":142580970},{"date":"2022-09-23","current":-5.117324,"twenty":-22.418277,"median":-21.131171,"eighty":-20.379723,"marketCap":142294950},{"date":"2022-09-30","current":-5.084236,"twenty":-22.409269,"median":-21.125878,"eighty":-20.356574,"marketCap":142580970},{"date":"2022-10-07","current":-5.099691,"twenty":-22.388089,"median":-21.120336,"eighty":-20.35202,"marketCap":142580970},{"date":"2022-10-14","current":-5.125907,"twenty":-22.322487,"median":-21.105916,"eighty":-20.310612,"marketCap":142866990},{"date":"2022-10-21","current":4.123596,"twenty":-22.31244,"median":-21.088579,"eighty":-20.274813,"marketCap":143153010},{"date":"2022-10-28","current":4.07957,"twenty":-22.287254,"median":-21.074661,"eighty":-20.256213,"marketCap":143582040},{"date":"2022-11-04","current":4.09622,"twenty":-22.281341,"median":-21.06757,"eighty":-20.156594,"marketCap":143725050},{"date":"2022-11-11","current":3.835525,"twenty":-22.267291,"median":-21.05741,"eighty":-20.116823,"marketCap":140221305},{"date":"2022-11-18","current":3.965158,"twenty":-22.266973,"median":-21.047582,"eighty":-20.01593,"marketCap":145441170},{"date":"2022-11-25","current":22.070496,"twenty":-22.256949,"median":-21.02751,"eighty":-19.909786,"marketCap":812319096},{"date":"2022-12-02","current":18.678955,"twenty":-22.224077,"median":-21.009565,"eighty":-9.20741,"marketCap":693258130},{"date":"2022-12-09","current":20.55276,"twenty":-22.194292,"median":-20.992495,"eighty":-9.076373,"marketCap":766661932},{"date":"2022-12-16","current":23.284761,"twenty":-22.183606,"median":-20.985866,"eighty":-5.170387,"marketCap":873913042},{"date":"2022-12-23","current":24.514364,"twenty":-22.180369,"median":-20.979037,"eighty":-5.136784,"marketCap":921625514},{"date":"2022-12-30","current":23.500927,"twenty":-22.176953,"median":-20.972644,"eighty":-5.116761,"marketCap":889001602},{"date":"2023-01-06","current":25.713628,"twenty":-22.168168,"median":-20.939833,"eighty":-5.097544,"marketCap":965994034},{"date":"2023-01-13","current":21.766355,"twenty":-22.156426,"median":-20.931009,"eighty":-5.061828,"marketCap":833540951},{"date":"2023-01-20","current":21.475872,"twenty":-22.142244,"median":-20.923268,"eighty":-5.030111,"marketCap":823753778},{"date":"2023-01-27","current":34.556535,"twenty":-22.087638,"median":-20.91043,"eighty":-4.995999,"marketCap":1327793218},{"date":"2023-02-03","current":27.072439,"twenty":-22.055719,"median":-20.885889,"eighty":-4.981646,"marketCap":1039887195},{"date":"2023-02-10","current":27.186532,"twenty":-22.037344,"median":-20.873676,"eighty":-4.977626,"marketCap":1027653228},{"date":"2023-02-17","current":28.847843,"twenty":-22.035695,"median":-20.845796,"eighty":-4.96732,"marketCap":1088823063},{"date":"2023-02-24","current":29.876152,"twenty":-22.029478,"median":-20.834633,"eighty":-4.95567,"marketCap":1115737790},{"date":"2023-03-03","current":27.302811,"twenty":-22.012361,"median":-20.798477,"eighty":-4.893553,"marketCap":1024390836},{"date":"2023-03-10","current":28.150355,"twenty":-21.957814,"median":-20.782106,"eighty":-4.871727,"marketCap":1062723933},{"date":"2023-03-17","current":28.619298,"twenty":-21.954448,"median":-20.755321,"eighty":-4.837995,"marketCap":1079851487},{"date":"2023-03-24","current":29.32388,"twenty":-21.934194,"median":-20.729118,"eighty":3.771219,"marketCap":1116553388},{"date":"2023-03-31","current":-12.752993,"twenty":-21.910612,"median":-20.706276,"eighty":3.835525,"marketCap":1081482682},{"date":"2023-04-06","current":-12.88881,"twenty":-21.90985,"median":-20.697321,"eighty":3.835227,"marketCap":1098610236},{"date":"2023-04-14","current":-12.801571,"twenty":-21.899263,"median":-20.678231,"eighty":3.825059,"marketCap":1104319421},{"date":"2023-04-21","current":-14.947443,"twenty":-21.850993,"median":-20.670206,"eighty":3.781482,"marketCap":1279672948},{"date":"2023-04-28","current":-13.55748,"twenty":-21.838695,"median":-20.645111,"eighty":3.746421,"marketCap":1166304854},{"date":"2023-05-05","current":-13.247519,"twenty":-21.837737,"median":-20.628022,"eighty":-3.085842,"marketCap":1137758931},{"date":"2023-05-12","current":-13.196444,"twenty":-21.830658,"median":-20.620294,"eighty":-4.801486,"marketCap":1124709366},{"date":"2023-05-19","current":-11.577513,"twenty":-21.820243,"median":-20.614435,"eighty":-4.83115,"marketCap":973024741},{"date":"2023-05-26","current":-12.873913,"twenty":-21.775441,"median":-20.581853,"eighty":-4.843609,"marketCap":1077686226},{"date":"2023-06-02","current":-13.4553,"twenty":-21.758764,"median":-20.576071,"eighty":-4.84735,"marketCap":1127563965},{"date":"2023-06-09","current":-11.336689,"twenty":-21.717141,"median":-20.565455,"eighty":-4.85482,"marketCap":953400713},{"date":"2023-06-16","current":-11.670779,"twenty":-21.688764,"median":-20.543917,"eighty":-4.866541,"marketCap":995114272},{"date":"2023-06-23","current":-11.565622,"twenty":-21.678904,"median":-20.533873,"eighty":-4.872917,"marketCap":989390525},{"date":"2023-06-30","current":-11.66219,"twenty":-21.66693,"median":-20.521238,"eighty":-4.875603,"marketCap":991025881},{"date":"2023-07-07","current":-11.380237,"twenty":-21.664978,"median":-20.517651,"eighty":-4.879205,"marketCap":964860181},{"date":"2023-07-14","current":-11.034638,"twenty":-21.662538,"median":-20.509733,"eighty":-4.882597,"marketCap":964042503},{"date":"2023-07-21","current":-11.170865,"twenty":-21.660191,"median":-20.495236,"eighty":-4.893553,"marketCap":971810445},{"date":"2023-07-28","current":-11.009662,"twenty":-21.656236,"median":-20.47859,"eighty":-4.916273,"marketCap":944418228},{"date":"2023-08-04","current":-10.763767,"twenty":-21.630704,"median":-20.475882,"eighty":-4.940196,"marketCap":919887885},{"date":"2023-08-11","current":-3.964027,"twenty":-21.619037,"median":-20.452843,"eighty":-4.879205,"marketCap":906805035},{"date":"2023-08-18","current":-4.026987,"twenty":-21.613502,"median":-20.440967,"eighty":-4.848908,"marketCap":909683857},{"date":"2023-08-25","current":-4.022548,"twenty":-21.606196,"median":-20.428933,"eighty":-4.792358,"marketCap":904744397},{"date":"2023-09-01","current":-3.768342,"twenty":-21.593859,"median":-20.420865,"eighty":-4.019699,"marketCap":848763852},{"date":"2023-09-08","current":-3.73793,"twenty":-21.590181,"median":-20.408566,"eighty":-4.001992,"marketCap":830652499},{"date":"2023-09-15","current":-3.712765,"twenty":-21.579562,"median":-20.380574,"eighty":-3.942259,"marketCap":822420066},{"date":"2023-09-22","current":-3.650753,"twenty":-21.575135,"median":-20.368501,"eighty":-3.858715,"marketCap":808424930},{"date":"2023-09-29","current":-3.421608,"twenty":-21.572125,"median":-20.356574,"eighty":-3.838428,"marketCap":750797898},{"date":"2023-10-06","current":-3.012194,"twenty":-21.570144,"median":-20.353296,"eighty":-3.76226,"marketCap":658594648},{"date":"2023-10-13","current":-2.686479,"twenty":-21.569768,"median":-20.346082,"eighty":-3.707338,"marketCap":588618966},{"date":"2023-10-20","current":-2.811146,"twenty":-21.56948,"median":-20.312815,"eighty":-3.654052,"marketCap":617432482},{"date":"2023-10-27","current":-2.375367,"twenty":-21.568992,"median":-20.309123,"eighty":-3.646351,"marketCap":519466528},{"date":"2023-11-03","current":-3.917302,"twenty":-21.567321,"median":-20.299111,"eighty":-3.544741,"marketCap":863582232},{"date":"2023-11-10","current":-3.597007,"twenty":-21.566303,"median":-20.266499,"eighty":-3.604286,"marketCap":800192497},{"date":"2023-11-17","current":-3.627589,"twenty":-21.562197,"median":-20.256213,"eighty":-3.537462,"marketCap":818303850},{"date":"2023-11-24","current":-3.529793,"twenty":-21.562057,"median":-20.239654,"eighty":-3.489083,"marketCap":799369254},{"date":"2023-12-01","current":-3.547582,"twenty":-21.5525,"median":-20.141357,"eighty":-3.52171,"marketCap":803485470},{"date":"2023-12-08","current":-3.307014,"twenty":-21.542769,"median":-20.122709,"eighty":-3.489083,"marketCap":740918979},{"date":"2023-12-15","current":-3.69562,"twenty":-21.533656,"median":-20.083807,"eighty":-3.52171,"marketCap":843824392},{"date":"2023-12-22","current":-4.035423,"twenty":-21.527619,"median":-20.01593,"eighty":-3.522576,"marketCap":921209263},{"date":"2023-12-29","current":-4.090708,"twenty":-21.52655,"median":-19.978248,"eighty":-3.526906,"marketCap":940967103},{"date":"2024-01-05","current":-4.344468,"twenty":-21.525358,"median":-19.920067,"eighty":-3.533351,"marketCap":988715215},{"date":"2024-01-12","current":-6.195434,"twenty":-21.52344,"median":-19.753335,"eighty":-3.548025,"marketCap":1408569303},{"date":"2024-01-19","current":-6.4217,"twenty":-21.52344,"median":-15.556029,"eighty":-3.549796,"marketCap":1448908225},{"date":"2024-01-26","current":-8.782403,"twenty":-21.52096,"median":-14.109091,"eighty":-3.557352,"marketCap":1976607187},{"date":"2024-02-02","current":-7.600825,"twenty":-21.513689,"median":-13.749102,"eighty":-3.569428,"marketCap":1712346084},{"date":"2024-02-09","current":-7.207212,"twenty":-21.513575,"median":-13.613957,"eighty":-3.588398,"marketCap":1611087157},{"date":"2024-02-16","current":-7.247938,"twenty":-21.506276,"median":-13.555523,"eighty":-3.597007,"marketCap":1619319590},{"date":"2024-02-23","current":-8.32854,"twenty":-21.504386,"median":-13.501613,"eighty":-3.6123,"marketCap":1870809159},{"date":"2024-03-01","current":-11.523207,"twenty":-21.501535,"median":-13.4553,"eighty":-3.617449,"marketCap":2038881713},{"date":"2024-03-08","current":-10.554531,"twenty":-21.497487,"median":-13.312518,"eighty":-3.621659,"marketCap":1867487103},{"date":"2024-03-15","current":-11.064095,"twenty":-21.496624,"median":-13.247519,"eighty":-3.626597,"marketCap":1957647810},{"date":"2024-03-22","current":-11.326445,"twenty":-21.490766,"median":-13.177305,"eighty":-3.630464,"marketCap":2004067183},{"date":"2024-03-28","current":-11.452575,"twenty":-21.477499,"median":-13.148196,"eighty":-3.631217,"marketCap":2026384190},{"date":"2024-04-05","current":-10.801745,"twenty":-21.466803,"median":-12.946408,"eighty":-3.632099,"marketCap":1911228436},{"date":"2024-04-12","current":-10.055058,"twenty":-21.461539,"median":-12.894895,"eighty":-3.633023,"marketCap":1779111758},{"date":"2024-04-19","current":-9.807844,"twenty":-21.456824,"median":-12.873913,"eighty":-3.633343,"marketCap":1735370425},{"date":"2024-04-26","current":-10.816881,"twenty":-21.455182,"median":-12.8124,"eighty":-3.637723,"marketCap":1913906477},{"date":"2024-05-03","current":-11.469203,"twenty":-21.453725,"median":-12.730824,"eighty":-3.642957,"marketCap":2029326298},{"date":"2024-05-10","current":-8.594704,"twenty":-21.447775,"median":-12.51454,"eighty":-3.64496,"marketCap":1965488386},{"date":"2024-05-17","current":-7.883065,"twenty":-21.443062,"median":-12.154706,"eighty":-3.648552,"marketCap":1802746667},{"date":"2024-05-24","current":-7.51567,"twenty":-21.440467,"median":-11.944691,"eighty":-3.653227,"marketCap":1718728474},{"date":"2024-05-31","current":-7.287445,"twenty":-21.438765,"median":-11.913972,"eighty":-3.657432,"marketCap":1666536719},{"date":"2024-06-07","current":-7.712415,"twenty":-21.436028,"median":-11.820873,"eighty":-3.667469,"marketCap":1763721366},{"date":"2024-06-14","current":-7.649457,"twenty":-21.431796,"median":-11.712329,"eighty":-3.679697,"marketCap":1749323640},{"date":"2024-06-21","current":-6.779842,"twenty":-21.425982,"median":-11.674804,"eighty":-3.69138,"marketCap":1550455058},{"date":"2024-06-28","current":-7.688806,"twenty":-21.424034,"median":-11.670779,"eighty":-3.693076,"marketCap":1758322219},{"date":"2024-07-05","current":-7.869811,"twenty":-21.420068,"median":-11.629156,"eighty":-3.69699,"marketCap":1799715680},{"date":"2024-07-12","current":-8.259367,"twenty":-21.415476,"median":-11.571568,"eighty":-3.704241,"marketCap":1888801606},{"date":"2024-07-15","current":-7.818658,"twenty":-21.415058,"median":-11.565622,"eighty":-3.706013,"marketCap":1788017528},{"date":"2024-08-02","current":-6.78968,"twenty":-21.414641,"median":-11.56183,"eighty":-3.707784,"marketCap":1552704702},{"date":"2024-08-09","current":-6.633158,"twenty":-21.412151,"median":-11.523207,"eighty":-3.71219,"marketCap":1521659607},{"date":"2024-08-16","current":-6.431294,"twenty":-21.410928,"median":-11.485219,"eighty":-3.714995,"marketCap":1475351701},{"date":"2024-08-23","current":-6.486229,"twenty":-21.403699,"median":-11.452575,"eighty":-3.729351,"marketCap":1487953851},{"date":"2024-08-30","current":-6.3175,"twenty":-21.396025,"median":-11.40917,"eighty":-3.756177,"marketCap":1449247247},{"date":"2024-09-06","current":-6.35674,"twenty":-21.393924,"median":-11.355092,"eighty":-3.77086,"marketCap":1458248783},{"date":"2024-09-13","current":-6.278261,"twenty":-21.387534,"median":-11.326445,"eighty":-3.775122,"marketCap":1440245712},{"date":"2024-09-20","current":-6.301805,"twenty":-21.376871,"median":-11.275775,"eighty":-3.783142,"marketCap":1445646633},{"date":"2024-09-27","current":-6.211555,"twenty":-21.365168,"median":-11.250767,"eighty":-3.799975,"marketCap":1424943101},{"date":"2024-10-04","current":-6.894316,"twenty":-21.350709,"median":-11.235632,"eighty":-3.813963,"marketCap":1581569822},{"date":"2024-10-11","current":-6.913935,"twenty":-21.347524,"median":-11.180631,"eighty":-3.822859,"marketCap":1586070590},{"date":"2024-10-18","current":-7.467207,"twenty":-21.343075,"median":-11.167175,"eighty":-3.825993,"marketCap":1712992243},{"date":"2024-10-25","current":-7.400501,"twenty":-21.342938,"median":-11.154909,"eighty":-3.828323,"marketCap":1697689633},{"date":"2024-10-31","current":-7.063044,"twenty":-21.342346,"median":-11.153652,"eighty":-3.831162,"marketCap":1620276426},{"date":"2024-11-08","current":-10.245268,"twenty":-21.340032,"median":-11.119592,"eighty":-3.843127,"marketCap":2037947682},{"date":"2024-11-15","current":-11.597233,"twenty":-21.336418,"median":-11.153652,"eighty":-3.852751,"marketCap":2306875223},{"date":"2024-11-22","current":-9.344667,"twenty":-21.331041,"median":-11.139145,"eighty":-3.855094,"marketCap":1858803744},{"date":"2024-11-29","current":-9.219266,"twenty":-21.330759,"median":-11.119592,"eighty":-3.856223,"marketCap":1833859559},{"date":"2024-12-06","current":-8.392551,"twenty":-21.326314,"median":-11.114547,"eighty":-3.859338,"marketCap":1669412707},{"date":"2024-12-13","current":-11.652967,"twenty":-21.305987,"median":-11.115575,"eighty":-3.87719,"marketCap":2317961528},{"date":"2024-12-20","current":-11.824812,"twenty":-21.294475,"median":-11.119592,"eighty":-3.877993,"marketCap":2352144301},{"date":"2024-12-27","current":-12.182436,"twenty":-21.26507,"median":-11.153652,"eighty":-3.894887,"marketCap":2423281422},{"date":"2025-01-03","current":-13.971232,"twenty":-21.256167,"median":-11.154909,"eighty":-3.910026,"marketCap":2779101565},{"date":"2025-01-10","current":-13.750577,"twenty":-21.252461,"median":-11.164306,"eighty":-3.918163,"marketCap":2735209745},{"date":"2025-01-17","current":-12.604247,"twenty":-21.239434,"median":-11.175748,"eighty":-3.920305,"marketCap":2507186388},{"date":"2025-01-24","current":-12.485847,"twenty":-21.225631,"median":-11.191789,"eighty":-3.922976,"marketCap":2483634680},{"date":"2025-01-31","current":-11.716245,"twenty":-21.222143,"median":-11.235632,"eighty":-3.931982,"marketCap":2330548577},{"date":"2025-02-07","current":-11.355662,"twenty":-21.212096,"median":-11.250762,"eighty":-3.948487,"marketCap":2258822920},{"date":"2025-02-14","current":-10.440751,"twenty":-21.20829,"median":-11.235632,"eighty":-3.960565,"marketCap":2076832448},{"date":"2025-02-21","current":-10.225478,"twenty":-21.200156,"median":-11.183444,"eighty":-3.964027,"marketCap":2034011161},{"date":"2025-02-28","current":-9.504592,"twenty":-21.195343,"median":-11.175748,"eighty":-3.98226,"marketCap":2296290448},{"date":"2025-03-07","current":-10.681871,"twenty":-21.178962,"median":-11.164306,"eighty":-3.997428,"marketCap":2580718582},{"date":"2025-03-14","current":-10.718234,"twenty":-21.176077,"median":-11.154835,"eighty":-4.003133,"marketCap":2589504006},{"date":"2025-03-21","current":-10.940963,"twenty":-21.161863,"median":-11.124637,"eighty":-4.016201,"marketCap":2643314734},{"date":"2025-03-28","current":-10.186414,"twenty":-21.161406,"median":-11.118097,"eighty":-4.018359,"marketCap":2461017166},{"date":"2025-04-04","current":-8.181858,"twenty":-21.151111,"median":-11.108408,"eighty":-4.019699,"marketCap":1976720616},{"date":"2025-04-11","current":-6.772761,"twenty":-21.131171,"median":-11.085541,"eighty":-4.022548,"marketCap":1636285398},{"date":"2025-04-17","current":-7.286399,"twenty":-21.131171,"median":-11.049366,"eighty":-4.026099,"marketCap":1760379526},{"date":"2025-04-25","current":-7.940948,"twenty":-21.129921,"median":-11.009301,"eighty":-4.031104,"marketCap":1918517175},{"date":"2025-05-02","current":-9.10459,"twenty":-21.123639,"median":-10.998302,"eighty":-4.034765,"marketCap":2199650774},{"date":"2025-05-09","current":-11.536892,"twenty":-21.121629,"median":-10.997201,"eighty":-4.055194,"marketCap":2161528945},{"date":"2025-05-16","current":-11.205615,"twenty":-21.120569,"median":-10.998302,"eighty":-4.084594,"marketCap":2099461659},{"date":"2025-05-23","current":-10.953938,"twenty":-21.111476,"median":-11.006409,"eighty":-4.290374,"marketCap":2052307975},{"date":"2025-05-30","current":-10.564438,"twenty":-21.108578,"median":-10.998097,"eighty":-4.342797,"marketCap":1979332035},{"date":"2025-06-06","current":-11.690992,"twenty":-21.105474,"median":-11.002458,"eighty":-4.35749,"marketCap":2190400908},{"date":"2025-06-13","current":-12.601823,"twenty":-21.102061,"median":-11.009662,"eighty":-4.386985,"marketCap":2361052337},{"date":"2025-06-20","current":-10.906,"twenty":-21.096009,"median":-11.034638,"eighty":-4.422768,"marketCap":2043326321},{"date":"2025-06-27","current":-11.055808,"twenty":-21.087156,"median":-11.017754,"eighty":-4.497549,"marketCap":2071393990},{"date":"2025-07-03","current":-11.894731,"twenty":-21.083291,"median":-11.017754,"eighty":-4.606816,"marketCap":2228572938},{"date":"2025-07-11","current":-13.195061,"twenty":-21.075684,"median":-11.055808,"eighty":-4.79464,"marketCap":2472200307},{"date":"2025-07-18","current":-13.171092,"twenty":-21.071944,"median":-11.081388,"eighty":-4.810613,"marketCap":2467709480},{"date":"2025-07-25","current":-14.016008,"twenty":-21.067824,"median":-11.091761,"eighty":-4.839398,"marketCap":2626011135},{"date":"2025-08-01","current":-13.069223,"twenty":-21.06562,"median":-11.111477,"eighty":-4.845791,"marketCap":2448623465},{"date":"2025-08-08","current":-15.555229,"twenty":-21.05775,"median":-11.119592,"eighty":-4.850879,"marketCap":2577734743},{"date":"2025-08-15","current":-17.10683,"twenty":-21.05745,"median":-11.126176,"eighty":-4.861355,"marketCap":2834858287},{"date":"2025-08-22","current":-16.610684,"twenty":-21.057344,"median":-11.154761,"eighty":-4.872322,"marketCap":2752639513},{"date":"2025-08-29","current":-16.277655,"twenty":-21.055392,"median":-11.163241,"eighty":-4.875603,"marketCap":2697451569},{"date":"2025-09-05","current":-17.439859,"twenty":-21.047582,"median":-11.170454,"eighty":-4.879205,"marketCap":2890046232},{"date":"2025-09-12","current":-18.078731,"twenty":-21.03344,"median":-11.181125,"eighty":-4.882597,"marketCap":2995916982},{"date":"2025-09-19","current":-18.167086,"twenty":-21.02751,"median":-11.201038,"eighty":-4.893553,"marketCap":3010558682},{"date":"2025-09-26","current":-17.868039,"twenty":-21.012624,"median":-11.225569,"eighty":-4.916273,"marketCap":2961002160},{"date":"2025-10-03","current":-20.865303,"twenty":-21.012022,"median":-11.235632,"eighty":-4.940196,"marketCap":3457693660},{"date":"2025-10-10","current":-22.4319,"twenty":-21.03344,"median":-11.250767,"eighty":-4.945659,"marketCap":3717302256},{"date":"2025-10-17","current":-24.786892,"twenty":-21.057477,"median":-11.275775,"eighty":-4.95567,"marketCap":4107559863},{"date":"2025-10-24","current":-24.661157,"twenty":-21.072958,"median":-11.313477,"eighty":-4.962071,"marketCap":4086723598},{"date":"2025-10-31","current":-26.316108,"twenty":-21.100962,"median":-11.330122,"eighty":-4.964584,"marketCap":4360973893},{"date":"2025-11-07","current":-18.875595,"twenty":-21.108122,"median":-11.343438,"eighty":-4.966514,"marketCap":4172884368},{"date":"2025-11-14","current":-18.680224,"twenty":-21.103709,"median":-11.369961,"eighty":-4.970546,"marketCap":4129693081},{"date":"2025-11-21","current":-19.341879,"twenty":-21.100962,"median":-11.403361,"eighty":-4.973006,"marketCap":4275967218},{"date":"2025-11-28","current":-21.18323,"twenty":-21.101511,"median":-11.425388,"eighty":-4.974245,"marketCap":4683040205},{"date":"2025-12-05","current":-18.387864,"twenty":-21.101511,"median":-11.450359,"eighty":-4.976938,"marketCap":4065060323},{"date":"2025-12-12","current":-18.551996,"twenty":-21.091056,"median":-11.462665,"eighty":-4.977903,"marketCap":4101345380},{"date":"2025-12-19","current":-17.387688,"twenty":-21.085733,"median":-11.47284,"eighty":-4.980017,"marketCap":3843948255},{"date":"2025-12-26","current":-18.285282,"twenty":-21.079828,"median":-11.497644,"eighty":-4.980806,"marketCap":4042382162},{"date":"2026-01-02","current":-17.992923,"twenty":-21.075002,"median":-11.504096,"eighty":-4.981179,"marketCap":3977749404},{"date":"2026-01-09","current":-18.362219,"twenty":-21.07093,"median":-11.523207,"eighty":-4.981835,"marketCap":4059390783},{"date":"2026-01-16","current":-16.325962,"twenty":-21.067761,"median":-11.540459,"eighty":-4.982647,"marketCap":3609229291},{"date":"2026-01-23","current":-17.854437,"twenty":-21.06562,"median":-11.56138,"eighty":-4.984708,"marketCap":3947133887},{"date":"2026-01-30","current":-16.125926,"twenty":-21.05775,"median":-11.577513,"eighty":-4.992071,"marketCap":3565006877},{"date":"2026-02-06","current":-16.443931,"twenty":-21.05745,"median":-11.596174,"eighty":-4.995999,"marketCap":3635309176},{"date":"2026-02-13","current":-17.880082,"twenty":-21.024533,"median":-11.596174,"eighty":-4.995999,"marketCap":3952803427},{"date":"2026-02-20","current":-19.534974,"twenty":-21.002589,"median":-11.596174,"eighty":-4.995999,"marketCap":3981598863},{"date":"2026-02-27","current":-19.337537,"twenty":-20.979211,"median":-11.596174,"eighty":-4.995999,"marketCap":3941357466},{"date":"2026-03-06","current":-17.00214,"twenty":-20.967512,"median":-11.596174,"eighty":-4.995999,"marketCap":3465359219},{"date":"2026-03-13","current":-16.821626,"twenty":-20.928367,"median":-11.596174,"eighty":-4.995999,"marketCap":3428567084},{"date":"2026-03-20","current":-17.182654,"twenty":-20.913737,"median":-11.596174,"eighty":-4.995999,"marketCap":3502151354},{"date":"2026-03-27","current":-17.628297,"twenty":-20.913737,"median":-11.596174,"eighty":-4.995999,"marketCap":3592981937},{"date":"2026-04-02","current":-18.508302,"twenty":-20.890277,"median":-11.596174,"eighty":-4.995999,"marketCap":3772343595},{"date":"2026-04-10","current":-19.78318,"twenty":-20.877597,"median":-11.596174,"eighty":-4.995999,"marketCap":4032188049},{"date":"2026-04-17","current":-18.728303,"twenty":-20.869146,"median":-11.596174,"eighty":-4.995999,"marketCap":3817184010},{"date":"2026-04-24","current":-17.74676,"twenty":-20.869146,"median":-11.596174,"eighty":-4.995999,"marketCap":3617126776},{"date":"2026-05-01","current":-16.110854,"twenty":-20.869146,"median":-11.596174,"eighty":-4.995999,"marketCap":3283698052},{"date":"2026-05-08","current":-19.659077,"twenty":-20.869146,"median":-11.596174,"eighty":-4.995999,"marketCap":4006893456},{"date":"2026-05-15","current":-19.932467,"twenty":-20.878577,"median":-11.596174,"eighty":-4.995999,"marketCap":4240293563},{"date":"2026-05-22","current":-19.640339,"twenty":-20.878577,"median":-11.596174,"eighty":-4.995999,"marketCap":4178148209},{"date":"2026-05-29","current":-19.464488,"twenty":-20.878577,"median":-11.597233,"eighty":-4.99438,"marketCap":4140738936},{"date":"2026-06-05","current":-17.95327,"twenty":-20.878577,"median":-11.661611,"eighty":-4.995999,"marketCap":3819252993},{"date":"2026-06-12","current":-16.628894,"twenty":-20.878577,"median":-11.682898,"eighty":-4.995999,"marketCap":3537514404},{"date":"2026-06-18","current":-16.568445,"twenty":-20.878577,"median":-11.682898,"eighty":-4.995999,"marketCap":3524654966},{"date":"2026-06-26","current":-17.436708,"twenty":-20.878577,"median":-11.674804,"eighty":-4.99438,"marketCap":3709363253},{"date":"2026-07-02","current":-19.327105,"twenty":-20.878577,"median":-11.674804,"eighty":-4.99438,"marketCap":4111512941},{"date":"2026-07-10","current":-19.739255,"twenty":-20.878577,"median":-11.674804,"eighty":-4.99438,"marketCap":4199190925},{"date":"2026-07-17","current":-17.063025,"twenty":-20.878577,"median":-11.674804,"eighty":-4.99438,"marketCap":3629868547},{"date":"2026-07-24","current":-16.788258,"twenty":-20.878577,"median":-11.674804,"eighty":-4.99438,"marketCap":3571416558},{"date":"2026-07-31","current":-15.639733,"twenty":-20.881502,"median":-11.672791,"eighty":-4.993803,"marketCap":3327087242},{"date":"2026-08-07","current":-12.465061,"twenty":-20.881502,"median":-11.672791,"eighty":-4.993803,"marketCap":3234733098},{"date":"2026-08-14","current":-12.285191,"twenty":-20.881502,"median":-11.672791,"eighty":-4.993803,"marketCap":3188056297},{"date":"2026-08-21","current":-12.796499,"twenty":-20.881502,"median":-11.672791,"eighty":-4.993803,"marketCap":3320742554},{"date":"2026-08-28","current":-12.340468,"twenty":-20.881502,"median":-11.672791,"eighty":-4.993803,"marketCap":3202400757}],"updateTime":1788230772236},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NAMS\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1181913423","title":"Stock Track | NewAmsterdam Pharma Soars 5.31% Intraday on Guggenheim's Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=1181913423","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181913423?lang=en_us&edition=fundamental","pubTime":"2026-05-08 21:49","pubTimestamp":1778248167,"startTime":"0","endTime":"0","summary":"NEWAMSTERDAM PHARMA CO NV (NAMS) saw its stock price soar 5.31% during intraday trading on Friday.The surge followed a positive analyst update from Guggenheim, where analyst Debjit Chattopadhyay...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["NAMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633236454","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2633236454","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633236454?lang=en_us&edition=fundamental","pubTime":"2026-05-08 21:41","pubTimestamp":1778247676,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on NewAmsterdam Pharma Company (NAMS), Insmed (INSM) an...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-155?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-155?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","LU0029874061.USD","LU0109394709.USD","LU0128526141.USD","LU0889565916.HKD","BK4139","BK4588","NAMS","BK4585","INSM","BLSG","XBI","BK4112","BLSX","LU0320765992.SGD","LABU","LU0053671581.USD","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633453245","title":"Guggenheim Sticks to Their Buy Rating for NewAmsterdam Pharma Company (NAMS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2633453245","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633453245?lang=en_us&edition=fundamental","pubTime":"2026-05-08 19:39","pubTimestamp":1778240359,"startTime":"0","endTime":"0","summary":"Guggenheim analyst Debjit Chattopadhyay maintained a Buy rating on NewAmsterdam Pharma Company yesterday and set a price target of $45.00. The comp...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/guggenheim-sticks-to-their-buy-rating-for-newamsterdam-pharma-company-nams-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/guggenheim-sticks-to-their-buy-rating-for-newamsterdam-pharma-company-nams-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NAMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633240781","title":"NewAmsterdam Pharma Company NV reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2633240781","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633240781?lang=en_us&edition=fundamental","pubTime":"2026-05-08 00:33","pubTimestamp":1778171631,"startTime":"0","endTime":"0","summary":"NewAmsterdam Pharma Company NV reports results for the quarter ended March 31 - Earnings SummaryNewAmsterdam Pharma Company NV NAMS.OQ reported a quarterly adjusted loss of 40 cents per share for the ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nL8N41K2JA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NAMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633145616","title":"NewAmsterdam Pharma Q1 net loss widens to USD 48.4 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633145616","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633145616?lang=en_us&edition=fundamental","pubTime":"2026-05-07 19:03","pubTimestamp":1778151810,"startTime":"0","endTime":"0","summary":"NewAmsterdam Pharma posted a net loss of USD 48.4 million in first-quarter 2026, worsening from a loss of USD 39.5 million a year earlier.Revenue held steady at USD 3 million, while operating loss narrowed to USD 58.4 million from USD 68.9 million.R&D expense fell to USD 38 million from USD 44.8 million, while SG&A costs dropped to USD 23.5 million from USD 27.2 million.Cash, cash equivalents and marketable securities totaled USD 707.3 million at March 31, down from USD 728.9 million at Dec. 31.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NewAmsterdam Pharma Company NV published the original content used to generate this news brief on May 07, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nNDLcgF8mG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NAMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633455991","title":"Press Release: NewAmsterdam Pharma Provides Corporate Update and Reports First Quarter Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2633455991","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633455991?lang=en_us&edition=fundamental","pubTime":"2026-05-07 19:00","pubTimestamp":1778151600,"startTime":"0","endTime":"0","summary":"-- PREVAIL interim analysis planned for 4Q2026 with result expected in 1Q2027 --. -- Completed enrollment in REMBRANDT; Topline data from RUBENS Phase 3 expected by year-end 2026 --. -- Presented new analyses of Phase 3 BROOKLYN and BROADWAY studies at the American College of Cardiology Annual Scientific Session  and simultaneously published in the American Journal of Preventative Cardiology--. -- $707.3 million in cash, cash equivalents and marketable securities at March 31, 2026 --. -- Management to host PREVAIL update call today at 8:00 AM ET --. NewAmsterdam is developing obicetrapib, an oral, low-dose and once-daily, highly-selective cholesteryl ester transfer protein  inhibitor, as a monotherapy and in fixed-dose combination with ezetimibe, as the preferred LDL-C lowering therapy to be used in patients at risk of CVD for whom existing therapies are not sufficiently effective or well-tolerated.In March 2026, NewAmsterdam presented results from additional analyses of its pivotal Ph","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NAMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632640170","title":"NewAmsterdam Pharma grants 50,400 inducement share options at $28.43 per share","url":"https://stock-news.laohu8.com/highlight/detail?id=2632640170","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632640170?lang=en_us&edition=fundamental","pubTime":"2026-05-02 04:57","pubTimestamp":1777669050,"startTime":"0","endTime":"0","summary":"NewAmsterdam Pharma granted inducement share options for 50,400 ordinary shares to five non-executive new hires on May 1, 2026.Option exercise price set at USD 28.43 per share.Options vest over four years, with 25% vesting at year one.Separate inducement restricted stock units for 15,400 ordinary shares were granted to five non-executive new hires on May 1, 2026.RSUs vest over three years in equal annual installments.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260501:nNDL2RHf0v:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","IE00BN0W2T93.GBP","BK4585","IE00B3QW5Z07.USD","IE00BKPKM429.USD","IE00B64PRP62.GBP","SG9999014013.SGD","NDAQ","SG9999014005.SGD","LU0314104364.USD","LU2095319765.USD","SG9999014039.USD","IE00BN0W2V16.EUR","NAMS","BK4112","SG9999014021.USD","LU2210150020.SGD","BK4588","IE00BN0W2W23.USD","BK4139","IE00BGHQF748.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630082761","title":"NewAmsterdam Pharma Chief Accounting Officer Louise Kooij to depart Aug. 31","url":"https://stock-news.laohu8.com/highlight/detail?id=2630082761","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630082761?lang=en_us&edition=fundamental","pubTime":"2026-04-25 04:32","pubTimestamp":1777062734,"startTime":"0","endTime":"0","summary":"NewAmsterdam Pharma set Aug. 31, 2026 as end date for Chief Accounting Officer Louise Kooij’s employment.Stock option and RSU vesting for Kooij extended through Jan. 10, 2027.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NewAmsterdam Pharma Company NV published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 24, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260424:nNDLzX2MW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAMS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190531077","title":"China National Investment & Guaranty Refutes Collaboration Claims with NAMS on Investment Products","url":"https://stock-news.laohu8.com/highlight/detail?id=1190531077","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190531077?lang=en_us&edition=fundamental","pubTime":"2026-04-23 15:41","pubTimestamp":1776930089,"startTime":"0","endTime":"0","summary":"China National Investment & Guaranty (CNIG) issued a statement on April 23 clarifying recent fraudulent activities. The company reported that it has received information indicating that unauthorized...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAMS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628740764","title":"NewAmsterdam Pharma announces annual shareholder meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2628740764","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628740764?lang=en_us&edition=fundamental","pubTime":"2026-04-20 20:01","pubTimestamp":1776686517,"startTime":"0","endTime":"0","summary":"NewAmsterdam Pharma set annual general meeting for June 2, 2026 in Amsterdam.Shareholders will vote on adoption of Dutch statutory annual accounts for fiscal year 2025.Ballot includes director discharge from liability for fiscal year 2025 actions.Items include auditor instruction, auditor ratification, reappointment of John W. Smither, reappointment of Janneke van der Kamp.Other votes cover share issuance authority, pre-emption rights exclusion authority, 2026 employee stock purchase plan, advisory approval of 2025 executive compensation.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NewAmsterdam Pharma Company NV published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Re","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nNDL2wB59Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NAMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625972646","title":"A Look At NewAmsterdam Pharma (NAMS) Valuation After Positive Obicetrapib Trial Sentiment And ACC.26 Data Presentations","url":"https://stock-news.laohu8.com/highlight/detail?id=2625972646","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625972646?lang=en_us&edition=fundamental","pubTime":"2026-04-05 15:29","pubTimestamp":1775374185,"startTime":"0","endTime":"0","summary":"Event driven interest in NewAmsterdam Pharma\nNewAmsterdam Pharma (NasdaqGM:NAMS) is back on investors’ radar after an investor letter highlighted optimism around trial outcomes for its CETP inhibitor obicetrapib, supported by new data presentations at the ACC.26 cardiology conference.\nSee our latest analysis for NewAmsterdam Pharma.\nNewAmsterdam Pharma’s recent presentations around obicetrapib, combined with the investor letter, come as the share price sits at US$32.99, with strong recent...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-nams/newamsterdam-pharma/news/a-look-at-newamsterdam-pharma-nams-valuation-after-positive-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-nams/newamsterdam-pharma/news/a-look-at-newamsterdam-pharma-nams-valuation-after-positive-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DCF","NAMS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624868099","title":"NewAmsterdam Pharma grants 15,000 inducement options under Nasdaq Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2624868099","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624868099?lang=en_us&edition=fundamental","pubTime":"2026-04-03 05:43","pubTimestamp":1775166234,"startTime":"0","endTime":"0","summary":"NewAmsterdam Pharma granted inducement share options covering 15,000 ordinary shares to two non-executive new hires.Options carry an exercise price of $32.81 per share, set at April 1 closing price.Option awards vest over four years, with 25% vesting after one year.Company also issued restricted stock units covering 3,200 ordinary shares to two non-executive new hires.RSU awards vest over three years, with one-third vesting each year.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260402:nNDL4vtrVW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU2095319765.USD","BK4588","IE00B64PRP62.GBP","NAMS","SG9999014005.SGD","NDAQ","SG9999014021.USD","IE00BN0W2W23.USD","IE00BN0W2V16.EUR","IE00BN0W2T93.GBP","LU2210150020.SGD","IE00BKPKM429.USD","IE00BGHQF748.EUR","SG9999014039.USD","LU0314104364.USD","IE00B3QW5Z07.USD","LU2210149790.SGD","SG9999014013.SGD","BK4139","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623392305","title":"Will ACC.26 Obicetrapib Data on Kidney, Safety and Lipids Change NewAmsterdam Pharma's (NAMS) Narrative?","url":"https://stock-news.laohu8.com/highlight/detail?id=2623392305","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623392305?lang=en_us&edition=fundamental","pubTime":"2026-03-30 15:05","pubTimestamp":1774854330,"startTime":"0","endTime":"0","summary":"NewAmsterdam Pharma announced it would present multiple Phase 3 and outcomes-related data sets for its oral CETP inhibitor obicetrapib at the ACC.26 cardiology meeting in New Orleans, highlighting kidney function, safety and lipid-related cardiovascular risk metrics in high‑risk patients.\nAn interesting angle for investors is that obicetrapib is being positioned as a low‑dose, oral option intended to complement or expand existing LDL‑lowering approaches, with European commercialization...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-nams/newamsterdam-pharma/news/will-acc26-obicetrapib-data-on-kidney-safety-and-lipids-chan","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-nams/newamsterdam-pharma/news/will-acc26-obicetrapib-data-on-kidney-safety-and-lipids-chan","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","NAMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622218851","title":"NewAmsterdam Pharma published BROADWAY trial presentation; pooled BROADWAY and BROOKLYN analysis shows slower annualized eGFR decline on obicetrapib vs placebo","url":"https://stock-news.laohu8.com/highlight/detail?id=2622218851","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622218851?lang=en_us&edition=fundamental","pubTime":"2026-03-26 19:15","pubTimestamp":1774523754,"startTime":"0","endTime":"0","summary":"NewAmsterdam Pharma published BROADWAY trial presentation; pooled BROADWAY and BROOKLYN analysis shows slower annualized eGFR decline on obicetrapib vs placebo. NewAmsterdam Pharma published a medical research presentation titled “CETP Inhibition With Obicetrapib Preserved Kidney Function in Patients at High Cardiovascular Risk: Results From the BROADWAY Trial.”The document reports a post hoc pooled analysis from the phase 3 BROADWAY and BROOKLYN randomized, double-blind, placebo-controlled trials evaluating obicetrapib 10 mg as an adjunct to lipid-lowering therapy over 1 year.In the pooled analysis, annualized eGFR change was -0.41 mL/min/1.73 m2 per year with obicetrapib versus -1.08 with placebo.Composite renal events were reported in 1.9% of obicetrapib-treated participants versus 3.0% with placebo.The presentation states there was no significant difference between groups in annualized changes in urine albumin-to-creatinine ratio.Disclaimer: This news brief was created by Public Te","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nNDL5K7MZJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAMS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622851211","title":"NewAmsterdam Pharma publishes pooled Phase III safety presentation on obicetrapib; TEAEs fall to 60.2% from 62.0%","url":"https://stock-news.laohu8.com/highlight/detail?id=2622851211","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622851211?lang=en_us&edition=fundamental","pubTime":"2026-03-26 19:15","pubTimestamp":1774523727,"startTime":"0","endTime":"0","summary":"NewAmsterdam published a medical research presentation titled “Safety of Obicetrapib: An Integrated Pooled Phase III Safety Analysis.”The pooled safety analysis included 2,880 participants from two phase 3 trials treated for 1 year with obicetrapib or placebo.Treatment-emergent adverse events were reported in 62% of placebo-treated participants and 60.2% of obicetrapib-treated participants.Deaths were reported in 1.5% of placebo-treated participants and 1.1% of obicetrapib-treated participants.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NewAmsterdam Pharma Company NV published the original content used to generate this news brief on March 25, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nNDL95Qrf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NAMS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622505019","title":"NewAmsterdam Pharma posts BROADWAY trial presentation on obicetrapib kidney outcomes","url":"https://stock-news.laohu8.com/highlight/detail?id=2622505019","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622505019?lang=en_us&edition=fundamental","pubTime":"2026-03-25 06:22","pubTimestamp":1774390951,"startTime":"0","endTime":"0","summary":"NewAmsterdam Pharma published a medical research presentation on CETP inhibition with obicetrapib and kidney function outcomes in patients at high cardiovascular risk, reporting results from the BROADWAY trial and a post hoc pooled analysis with the BROOKLYN trial.The pooled analysis included 2,832 randomized participants with at least 1 postbaseline eGFR assessment and 1,897 participants with at least 1 postbaseline UACR measurement.Annualized eGFR decline was -0.41 mL/min/1.73 m2 per year with obicetrapib versus -1.08 mL/min/1.73 m2 per year with placebo, with a reported difference of 0.67 and nominal P=0.02.Composite renal events were reported in 1.9% of participants on obicetrapib versus 3.0% on placebo.The presentation reported no significant difference between groups in annualized changes in UACR.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nNDL5nzm7R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NAMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621041708","title":"NewAmsterdam Pharma to present BROADWAY trial results on obicetrapib at ACC.26","url":"https://stock-news.laohu8.com/highlight/detail?id=2621041708","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621041708?lang=en_us&edition=fundamental","pubTime":"2026-03-23 20:02","pubTimestamp":1774267371,"startTime":"0","endTime":"0","summary":"NewAmsterdam said three digital poster presentations on obicetrapib and lipid-related cardiovascular risk analyses will be presented at ACC.26 on March 28-30, 2026, in New Orleans.One presentation will report BROADWAY trial results on kidney function in patients at high cardiovascular risk receiving obicetrapib, presented by John Kastelein.Another poster will examine cardiovascular events in people with normal LDL-C but high small/medium LDL particles, presented by Floriaan Schmidt on March 30, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nNDL99sL0X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","BK4588","BK4139","IE00BN0W2T93.GBP","NDAQ","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","SG9999014013.SGD","SG9999014005.SGD","BK4112","BK4585","LU0314104364.USD","IE00BN0W2V16.EUR","LU2095319765.USD","NAMS","IE00BN0W2W23.USD","SG9999014039.USD","IE00BKPKM429.USD","SG9999014021.USD","LU2210149790.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620415352","title":"Truist Initiates NewAmsterdam Pharma at Buy With $57 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2620415352","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620415352?lang=en_us&edition=fundamental","pubTime":"2026-03-19 18:43","pubTimestamp":1773917023,"startTime":"0","endTime":"0","summary":"NewAmsterdam Pharma (NAMS) has an average rating of buy and mean price target of $50.29, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","NAMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620264938","title":"NewAmsterdam Pharma initiated with a Buy at Truist","url":"https://stock-news.laohu8.com/highlight/detail?id=2620264938","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620264938?lang=en_us&edition=fundamental","pubTime":"2026-03-19 03:50","pubTimestamp":1773863417,"startTime":"0","endTime":"0","summary":"Truist initiated coverage of NewAmsterdam Pharma (NAMS) with a Buy rating and $57 price target The stock significantly outperformed in 2024 and 202...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/newamsterdam-pharma-initiated-with-a-buy-at-truist-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/newamsterdam-pharma-initiated-with-a-buy-at-truist-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NAMS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617630728","title":"NewAmsterdam Pharma Reports Nasdaq-Rule Inducement Grants Under 2024 Inducement Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2617630728","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2617630728?lang=en_us&edition=fundamental","pubTime":"2026-03-07 05:01","pubTimestamp":1772830878,"startTime":"0","endTime":"0","summary":"NewAmsterdam Pharma said its board compensation committee approved inducement equity awards for two non-executive new hires, including options for 10,000 ordinary shares at an exercise price of $32.83, set at the March 2, 2026 closing price. The options vest over four years, with 25% vesting after one year and the remainder in 36 equal monthly installments, subject to continued service. The company also granted 2,200 restricted stock units to two non-executive new hires, vesting in three equal annual installments over three years, subject to continued service.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260306:nNDL36pr9d:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","IE00BGHQF748.EUR","IE00BKPKM429.USD","NAMS","SG9999014005.SGD","BK4139","BK4588","LU0314104364.USD","BK4585","LU2095319765.USD","LU2210149790.SGD","SG9999014013.SGD","SG9999014021.USD","BK4112","NDAQ","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","SG9999014039.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":61,"code":"91000000","status":"200"}]}}